Tandem Diabetes Care, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 191.67 million compared to USD 169.38 million a year ago. Net loss was USD 42.72 million compared to USD 123.87 million a year ago.

Basic loss per share from continuing operations was USD 0.65 compared to USD 1.92 a year ago. Diluted loss per share from continuing operations was USD 0.65 compared to USD 1.92 a year ago.